secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cyclerion Therapeutics, Inc. (CYCN)
CIK:        0001755237
Form:       8-K
Filed at:   2023-10-23T23:59:59+00:00
Accession:  0001140361-23-049190
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclerion CFO Anjeza Gjino to resign; separation includes up to $430K in cash payments
--------------------------------------------------------------------------------

- CFO Anjeza Gjino to resign after Q3 2023 10-Q filing; resignation not due to any disagreement.
- Receives $226K lump sum on separation, plus $102K each at 6- and 9-month anniversaries if still unemployed.
- Vested stock options exercisable for 2 years post-separation; unvested options terminate on effective date.
- Non-compete limited to 6 months; agreement includes confidentiality, non-disparagement, and general release.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1755237/000114036123049190/0001140361-23-049190-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1755237/000114036123049190/ef20013008_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-049190

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer